arrowTo report an adverse event

arrowFor any other medical emergency or R&D questions


Choose site

Rottapharm | Madaus
is now part of Meda AB

Rottapharm|Madaus' Production plant : Ireland

The manufacturing facility located in Ireland (Dublin) was built in 1998 and expanded in 2009. The total area of the plant amounts to 10,200 sqm, with a recent extension of 1,800 sqm.
At the Dublin plant, the activities carried out are primarily the preparation and packaging of oral solids (sachets, tablets and capsules) and the preparation of crystalline glucosamine sulfate.
The production facility is under expansion and new production units will be ready by the first half of 2015. The Dublin plant holds numerous certifications, including the license granted by the Irish Medical Committee (Irish Medicines Board), the Brazilian ANVISA certification and the German certification for medical devices (TUV); the certification in Saudi Arabia is currently in progress.

The Dublin plant was the first to adopt a leaner production strategy, then extended to the entire production system of the Group, which uses modern techniques of control, also automatic, of production to achieve high quality at low cost.

Furthermore, as evidence of the attention paid by the Rottapharm | Madaus Group to sustainability, in 2013, CEFIC, forum and voice of the European Chemical Associations, awarded the Irish site with the “SME Responsible Care Award” for having introduced “green” initiatives that reduced carbon dioxide emissions by 25%, energy consumption by 37% and energy production per unit by 47 %, through a cultural change, which involved the entire staff of the plant.

Rottapharm LTD
Damastown Industrial Park Mulhuddart
Phone: +353-1-8852700  
Fax: +353-1-8852792